EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma
EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma Mon, 1st Mar 2021 16:41 (Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Sensyne Health PLC - Oxford, England-based clinical technology using artificial intelligence - Moves Chief Investment Officer Richard Pye to chief financial officer and executive director, while interim CFO Michael Norris moves to non-executive director, both from last Friday. Norris has been interim CFO since March last year. Additionall...
Source: lse.co.uk